Fillers & Botulinum Toxin
Botulinum Toxin Injection Areas: Expression, Function, and Secretion
Botulinum toxin type A reduces muscle contraction by inhibiting release of acetylcholine, the messenger that tells a muscle to contract. An injection site alone cannot define a treatment. Expression lines, muscle-function problems, and secretion problems have different aims and product-specific authorized uses. The cited sources discuss facial lines, hyperhidrosis, eyelid spasm, and severe drooling in some children and adolescents. Each needs its own assessment. Systemic symptoms after excessive botulinum toxin injection require immediate medical evaluation.
- Expression, function, and secretion each have their own aim and use scope.
- An area or symptom name alone cannot establish whether an injection is appropriate.
- Drooping eyelids, visual changes, swallowing or speech difficulty, breathing difficulty, or generalized weakness need immediate assessment.
People sometimes call a botulinum toxin injection “Botox.” Here the subject is the generic type A substance and the clinical aims described in the sources, not a finding for a branded product. The injection location alone does not tell you whether the concern is facial expression, muscle function, or secretion.
Mechanism and authorized-use scope
At nerve endings, botulinum toxin type A inhibits acetylcholine release and reduces muscle contraction. The mechanism is shared, but authorized use still depends on the product and clinical aim.
| Aim | What the sources describe | Question to clarify |
|---|---|---|
| Expression | The Korean Dermatological Association considers the face at rest and during expressions. The forehead, the area between the eyebrows, and the outer eye area are examples; a visible line alone does not establish an indication. | Does the line change with expression, and what skin changes are present at rest? |
| Function | Eyelid spasm, facial spasm, and neck muscle tension belong to medical contexts involving movement and symptoms. | Is the concern appearance, or is movement, eating, or swallowing affected? Is another condition or medicine relevant? |
| Secretion | Seoul National University Hospital discusses hyperhidrosis; Seoul National University Children’s Hospital describes injection for severe drooling in some pediatric patients. | Is the concern the amount of sweat or saliva, or visible bulk and contour? What diagnosis and product-specific use apply? |
The sources describe different patient groups
Site names cannot establish who is eligible. Seoul National University Hospital discusses wrinkles and hyperhidrosis alongside eyelid spasm, facial spasm, and muscle-tension conditions. Seoul National University Children’s Hospital describes treatment for severe drooling in some children and adolescents. That pediatric account cannot be applied to an adult facial-contour concern or every salivary-gland situation.
Korea’s official medicines database lists individual products. Check each product’s stated use; finding one in the database does not make every site in this article interchangeable.
Systemic symptoms after excessive injection need urgent assessment
The Korea Disease Control and Prevention Agency says excessive botulinum toxin injection for cosmetic or therapeutic purposes can also cause botulism. It lists drooping eyelids, double or blurred vision, difficulty swallowing, speaking, or breathing, and generalized weakness. Treatment should begin as soon as possible, the agency says. Seek immediate medical assessment if these changes occur; do not set a waiting period by injection site or try to identify the cause yourself.
References
- Korean Dermatological Association, “보툴리눔독소, 필러” (in Korean). https://www.derma.or.kr/new/general/treatment.php?mod=document&uid=1118
- Seoul National University Hospital, “보툴리눔 독소 시술법 [botulinum toxin therapy]” (in Korean). https://www.snuh.org/health/nMedInfo/nView.do?medid=BB000140
- Seoul National University Hospital, “주름살 [wrinkle]” (in Korean). https://www.snuh.org/health/nMedInfo/nView.do?medid=AA000739
- Asan Medical Center, “보툴리눔 독소 주사 치료” (in Korean). https://www.amc.seoul.kr/asan/healthinfo/management/managementDetail.do?managementId=422
- Seoul National University Children’s Hospital, “소아재활의학과” (in Korean). https://child.snuh.org/reservation/meddept/PRH/childIntro.do
- Korea Disease Control and Prevention Agency, “보툴리눔독소증” (in Korean). https://health.kdca.go.kr/healthinfo/biz/health/gnrlzHealthInfo/gnrlzHealthInfo/gnrlzHealthInfoView.do?cntnts_sn=5842
- Ministry of Food and Drug Safety, “의약품등 정보검색” (in Korean). https://nedrug.mfds.go.kr/searchDrug
- Beyond Clinic YouTube video (in Korean), uploaded September 15, 2026. https://www.youtube.com/watch?v=PZUnGlQgVPw
Frequently asked questions
Can facial botulinum toxin type A injection sites be listed all at once?
The forehead, the area between the eyebrows, and the outer eye area are examples for expression lines. A site list cannot determine whether an injection is appropriate for one person. Start by distinguishing expression, muscle function, and secretion.
Is every visible wrinkle an expression-line target?
No. Muscle movement and changes in the skin can contribute differently to a line that appears with an expression and one that remains at rest. A clinician must assess the individual cause.
Does concern about the salivary-gland area necessarily mean a secretion problem?
No. Visible bulk or contour is different from the amount of saliva. A pediatric hospital describes treatment for severe drooling in some children and adolescents; that account does not apply automatically to an adult facial-contour concern. Tell a clinician which issue you mean.
Which changes after an injection need immediate assessment?
Seek immediate medical assessment for a drooping eyelid, double or blurred vision, difficulty swallowing, speaking, or breathing, or generalized weakness. Do not wait for a site-specific timetable or try to diagnose the cause from this list.